CIK 0001819576
- Non-accelerated filer
Liquidia Corp
Sign in to watch- Ticker
- LQDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851710962
- Phone
- +1 919-328-4400
- Business address
- 419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC, 27560
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,032,584
- in 16 filings, $9.5M under 10b5-1 plans
Net −$17,032,584. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-01 | Boyle Dana Chief Accounting Officer | Grant or award | +25,000 | 188,361 | ||
| 2025-06-17 | SINGH RAMAN Director | Grant or award | +18,396 | 38,755 | ||
| 2025-06-17 | Rielly-Gauvin Katherine Director | Grant or award | +18,396 | 38,755 | ||
| 2025-06-17 | Manning Paul B Director | Grant or award | +18,396 | 38,755 | ||
| 2025-06-17 | Kirsch Arthur S Director | Grant or award | +18,396 | 40,755 | ||
| 2025-06-17 | Horobin Joanna Director | Grant or award | +18,396 | 38,755 | ||
| 2025-06-17 | deGoa Damian Director | Grant or award | +18,396 | 86,471 | ||
| 2025-06-17 | Bloch Stephen M Director | Grant or award | +18,396 | 38,755 | ||
| 2025-06-17 | JOHNSON DAVID EDWARD Director | Grant or award | +18,396 | 38,755 | ||
| 2025-06-04 | Schundler Russell General Counsel | Sale 10b5-1 | −8,460 | $16.97 | $144K | 582,054 |
| 2025-06-04 | Saggar Rajeev Chief Medical Officer | Sale 10b5-1 | −7,597 | $16.97 | $129K | 273,209 |
| 2025-06-04 | Moomaw Scott Chief Commercial Officer | Sale 10b5-1 | −6,656 | $16.97 | $113K | 224,921 |
| 2025-06-04 | Kaseta Michael CFO and COO | Sale 10b5-1 | −14,777 | $16.97 | $251K | 412,164 |
| 2025-06-04 | JEFFS ROGER Chief Executive Officer | Sale 10b5-1 | −30,610 | $16.97 | $519K | 1,044,979 |
| 2025-06-04 | Adair Jason Chief Business Officer | Sale 10b5-1 | −3,597 | $16.97 | $61K | 193,735 |
| 2025-06-03 | Schundler Russell General Counsel | Exercise or conversion 10b5-1 | +18,792 | 590,514 | ||
| 2025-06-03 | Schundler Russell General Counsel | Exercise or conversion · Performance Stock Units 10b5-1 | −18,792 | 41,343 | ||
| 2025-06-03 | Saggar Rajeev Chief Medical Officer | Exercise or conversion 10b5-1 | +17,654 | 280,806 | ||
| 2025-06-03 | Saggar Rajeev Chief Medical Officer | Exercise or conversion · Performance Stock Units 10b5-1 | −17,654 | 38,838 | ||
| 2025-06-03 | Moomaw Scott Chief Commercial Officer | Exercise or conversion 10b5-1 | +15,539 | 231,577 |
Page 25 of 29 · 579 trades